fatrovax rhd
fatro s.p.a - rabbit hemorrhagic disease virus 2 vp1ab, rabbit hemorrhagic disease virus vp1a - Ónæmislyf fyrir leporidae - kanínur - for active immunisation of rabbits from the age of 28 days to reduce mortality, infection, clinical signs and organ lesions of rabbit haemorrhagic disease caused by rhdv1 and rhdv2.
mycapssa
amryt pharmaceuticals dac - octreotide acetate - acromegaly - hinsveiflur og heilahimnubólur og hliðstæður - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.
hemgenix
csl behring gmbh - etranacogene dezaparvovec - hemophilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.
treo citrus freyðitafla 500/50 mg
viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500/50 mg
paratabs filmuhúðuð tafla 500 mg
teva b.v.* - paracetamolum inn - filmuhúðuð tafla - 500 mg
meropenem sun stungulyfs-/innrennslisstofn, lausn 1 g
sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g
metronidazol actavis filmuhúðuð tafla 500 mg
actavis group ptc ehf. - metronidazolum inn - filmuhúðuð tafla - 500 mg
metronidazol actavis filmuhúðuð tafla 250 mg
actavis group ptc ehf. - metronidazolum inn - filmuhúðuð tafla - 250 mg
livostin nefúði, dreifa 0,5 mg/ml
mcneil sweden ab - levocabastinum hýdróklóríð - nefúði, dreifa - 0,5 mg/ml
meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 500 mg
williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg